S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)

AdaptHealth Stock Price, News & Analysis (NASDAQ:AHCO)

$8.56
-0.64 (-6.96%)
(As of 04:00 PM ET)
Compare
Today's Range
$8.28
$9.23
50-Day Range
$6.50
$9.20
52-Week Range
$6.37
$23.00
Volume
725,427 shs
Average Volume
1.27 million shs
Market Capitalization
$1.17 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.83

AdaptHealth MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
64.6% Upside
$13.83 Price Target
Short Interest
Bearish
11.51% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of AdaptHealth in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
24.19%
From $0.62 to $0.77 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.28 out of 5 stars

Medical Sector

303rd out of 949 stocks

Home Health Care Services Industry

4th out of 6 stocks


AHCO stock logo

About AdaptHealth Stock (NASDAQ:AHCO)

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

AHCO Stock Price History

AHCO Stock News Headlines

The Battery Metal Nobody Told You About
According to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy. Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech."
AHCO NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL,...
The Battery Metal Nobody Told You About
According to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy. Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech."
Analyst Expectations for AdaptHealth's Future
Why AdaptHealth Stock Trading Is Lower Today
AdaptHealth Turns To Q3 Loss, But Revenue Increases
AdaptHealth Corp. Announces Third Quarter 2023 Results
AdaptHealth Q3 2023 Earnings Preview
See More Headlines
Receive AHCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Today
12/05/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/26/2024

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AHCO
Fax
N/A
Employees
10,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.83
High Stock Price Target
$23.00
Low Stock Price Target
$6.50
Potential Upside/Downside
+61.5%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

Net Income
$69.32 million
Pretax Margin
-14.38%

Debt

Sales & Book Value

Annual Sales
$2.97 billion
Cash Flow
$3.01 per share
Book Value
$16.01 per share

Miscellaneous

Free Float
117,841,000
Market Cap
$1.17 billion
Optionable
Not Optionable
Beta
0.87
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives















AHCO Stock Analysis - Frequently Asked Questions

Should I buy or sell AdaptHealth stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AHCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AHCO, but not buy additional shares or sell existing shares.
View AHCO analyst ratings
or view top-rated stocks.

What is AdaptHealth's stock price target for 2024?

6 brokers have issued 12 month price targets for AdaptHealth's stock. Their AHCO share price targets range from $6.50 to $23.00. On average, they predict the company's stock price to reach $13.83 in the next year. This suggests a possible upside of 64.6% from the stock's current price.
View analysts price targets for AHCO
or view top-rated stocks among Wall Street analysts.

How have AHCO shares performed in 2023?

AdaptHealth's stock was trading at $19.22 at the beginning of the year. Since then, AHCO shares have decreased by 56.3% and is now trading at $8.40.
View the best growth stocks for 2023 here
.

When is AdaptHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 26th 2024.
View our AHCO earnings forecast
.

How were AdaptHealth's earnings last quarter?

AdaptHealth Corp. (NASDAQ:AHCO) issued its quarterly earnings data on Tuesday, November, 7th. The company reported $0.19 EPS for the quarter, meeting analysts' consensus estimates of $0.19. The business earned $804.03 million during the quarter, compared to analysts' expectations of $796.60 million. AdaptHealth had a positive trailing twelve-month return on equity of 4.09% and a negative net margin of 13.68%. The business's revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.11 earnings per share.

What other stocks do shareholders of AdaptHealth own?
Who are AdaptHealth's major shareholders?

AdaptHealth's stock is owned by a number of institutional and retail investors. Top institutional investors include Deerfield Management Company L.P. Series C (10.00%), FMR LLC (6.49%), SkyKnight Capital L.P. (6.30%), Reinhart Partners LLC. (2.66%), Rubric Capital Management LP (1.44%) and Rubric Capital Management LP (1.44%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Albert A Prast, Assured Investment Management, Christopher J Joyce, Dale B Wolf, Daniel Bunting, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Aero Holdings, Llc, Skyknight Capital Fund Ii, LP and Stephen P Griggs.
View institutional ownership trends
.

How do I buy shares of AdaptHealth?

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:AHCO) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -